Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gold | 36 | 2025 | 153 | 8.910 |
Why?
|
| Metal Nanoparticles | 33 | 2025 | 227 | 7.490 |
Why?
|
| Graphite | 9 | 2025 | 61 | 3.420 |
Why?
|
| Nanostructures | 12 | 2016 | 158 | 3.280 |
Why?
|
| Spectrum Analysis, Raman | 15 | 2017 | 94 | 3.150 |
Why?
|
| Biocompatible Materials | 4 | 2025 | 106 | 2.980 |
Why?
|
| Neoplastic Cells, Circulating | 6 | 2018 | 25 | 2.550 |
Why?
|
| Nanotechnology | 11 | 2017 | 176 | 2.490 |
Why?
|
| Aptamers, Nucleotide | 9 | 2021 | 51 | 2.400 |
Why?
|
| Nanoparticles | 10 | 2023 | 449 | 2.200 |
Why?
|
| Anti-Bacterial Agents | 8 | 2025 | 415 | 2.190 |
Why?
|
| Phototherapy | 7 | 2023 | 25 | 1.780 |
Why?
|
| Oxides | 6 | 2025 | 97 | 1.690 |
Why?
|
| Exosomes | 2 | 2025 | 124 | 1.520 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 5 | 2016 | 34 | 1.510 |
Why?
|
| Colorimetry | 6 | 2011 | 52 | 1.450 |
Why?
|
| Particle Size | 10 | 2025 | 267 | 1.420 |
Why?
|
| Cell Separation | 3 | 2018 | 94 | 1.350 |
Why?
|
| Silver | 5 | 2025 | 61 | 1.310 |
Why?
|
| Surface Properties | 11 | 2025 | 157 | 1.260 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 4 | 2025 | 62 | 1.170 |
Why?
|
| Salmonella | 3 | 2013 | 12 | 1.140 |
Why?
|
| Prostatic Neoplasms | 6 | 2017 | 1068 | 1.120 |
Why?
|
| Photons | 3 | 2015 | 29 | 1.110 |
Why?
|
| Energy Transfer | 4 | 2021 | 32 | 1.100 |
Why?
|
| Diagnostic Imaging | 3 | 2016 | 53 | 1.050 |
Why?
|
| Environmental Pollutants | 6 | 2011 | 198 | 1.030 |
Why?
|
| Biosensing Techniques | 3 | 2021 | 130 | 1.020 |
Why?
|
| Bacteria | 4 | 2023 | 285 | 1.010 |
Why?
|
| Nanotubes, Carbon | 4 | 2016 | 87 | 0.980 |
Why?
|
| Magnetics | 3 | 2016 | 43 | 0.980 |
Why?
|
| Cell Line, Tumor | 16 | 2025 | 2598 | 0.960 |
Why?
|
| Doxycycline | 1 | 2025 | 32 | 0.930 |
Why?
|
| Hyperthermia, Induced | 3 | 2015 | 27 | 0.930 |
Why?
|
| Fluorescent Dyes | 3 | 2016 | 182 | 0.930 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2016 | 57 | 0.900 |
Why?
|
| Sunlight | 1 | 2025 | 48 | 0.890 |
Why?
|
| Nanowires | 1 | 2023 | 9 | 0.800 |
Why?
|
| Materials Testing | 4 | 2025 | 99 | 0.790 |
Why?
|
| Scattering, Radiation | 4 | 2011 | 43 | 0.790 |
Why?
|
| Optical Phenomena | 6 | 2014 | 18 | 0.750 |
Why?
|
| DNA | 3 | 2012 | 594 | 0.700 |
Why?
|
| Antigens, Viral | 1 | 2021 | 50 | 0.690 |
Why?
|
| Quantum Dots | 2 | 2025 | 38 | 0.670 |
Why?
|
| Mercury | 2 | 2011 | 39 | 0.620 |
Why?
|
| Photochemotherapy | 3 | 2014 | 42 | 0.610 |
Why?
|
| Molecular Probes | 2 | 2017 | 23 | 0.610 |
Why?
|
| Nanomedicine | 3 | 2015 | 52 | 0.610 |
Why?
|
| Environmental Monitoring | 2 | 2011 | 226 | 0.600 |
Why?
|
| Humans | 32 | 2025 | 42163 | 0.600 |
Why?
|
| Hepacivirus | 2 | 2009 | 73 | 0.580 |
Why?
|
| Membranes, Artificial | 2 | 2015 | 33 | 0.580 |
Why?
|
| Prostate | 2 | 2017 | 152 | 0.570 |
Why?
|
| Neoplasms | 3 | 2014 | 1341 | 0.570 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 479 | 0.550 |
Why?
|
| Salmonella typhimurium | 3 | 2015 | 40 | 0.550 |
Why?
|
| RNA, Viral | 2 | 2009 | 317 | 0.530 |
Why?
|
| Antineoplastic Agents | 1 | 2025 | 979 | 0.520 |
Why?
|
| tau Proteins | 3 | 2016 | 182 | 0.510 |
Why?
|
| Zinc | 1 | 2017 | 130 | 0.480 |
Why?
|
| Microscopy, Electron, Transmission | 7 | 2012 | 160 | 0.480 |
Why?
|
| Disinfection | 1 | 2015 | 10 | 0.480 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2015 | 25 | 0.470 |
Why?
|
| Escherichia coli O157 | 1 | 2015 | 17 | 0.470 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 94 | 0.470 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2015 | 16 | 0.470 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2025 | 232 | 0.460 |
Why?
|
| Water Purification | 1 | 2015 | 33 | 0.460 |
Why?
|
| Photosensitizing Agents | 3 | 2014 | 55 | 0.460 |
Why?
|
| Alzheimer Disease | 2 | 2015 | 972 | 0.450 |
Why?
|
| Metals, Heavy | 1 | 2015 | 69 | 0.450 |
Why?
|
| Melanoma | 1 | 2015 | 109 | 0.430 |
Why?
|
| Trinitrotoluene | 2 | 2011 | 15 | 0.430 |
Why?
|
| Refractometry | 2 | 2011 | 16 | 0.430 |
Why?
|
| Monitoring, Physiologic | 2 | 2011 | 37 | 0.420 |
Why?
|
| Limit of Detection | 3 | 2021 | 82 | 0.420 |
Why?
|
| Salmonella Infections | 1 | 2013 | 16 | 0.420 |
Why?
|
| Surface Plasmon Resonance | 1 | 2013 | 35 | 0.390 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 69 | 0.390 |
Why?
|
| Rhodium | 1 | 2012 | 2 | 0.380 |
Why?
|
| Escherichia coli | 2 | 2025 | 461 | 0.370 |
Why?
|
| Radiotherapy | 1 | 2012 | 21 | 0.370 |
Why?
|
| Nanotubes | 2 | 2010 | 17 | 0.360 |
Why?
|
| Cyanides | 1 | 2011 | 14 | 0.360 |
Why?
|
| Reactive Oxygen Species | 4 | 2023 | 518 | 0.350 |
Why?
|
| Ferric Compounds | 1 | 2012 | 62 | 0.350 |
Why?
|
| Paint | 1 | 2011 | 5 | 0.350 |
Why?
|
| Plastics | 1 | 2011 | 13 | 0.350 |
Why?
|
| Light | 4 | 2013 | 182 | 0.350 |
Why?
|
| Tryptophan | 1 | 2011 | 66 | 0.350 |
Why?
|
| Breast Neoplasms | 3 | 2011 | 1679 | 0.350 |
Why?
|
| Iron | 1 | 2013 | 247 | 0.340 |
Why?
|
| Crystallization | 1 | 2010 | 88 | 0.340 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 205 | 0.320 |
Why?
|
| Lead | 1 | 2011 | 101 | 0.310 |
Why?
|
| Water | 2 | 2013 | 314 | 0.310 |
Why?
|
| Hot Temperature | 3 | 2016 | 141 | 0.300 |
Why?
|
| Fluorescence | 2 | 2025 | 113 | 0.300 |
Why?
|
| Fresh Water | 1 | 2009 | 48 | 0.290 |
Why?
|
| Water Pollutants, Chemical | 1 | 2011 | 170 | 0.290 |
Why?
|
| Molecular Structure | 4 | 2017 | 560 | 0.280 |
Why?
|
| Magnesium | 1 | 2008 | 93 | 0.280 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2007 | 11 | 0.270 |
Why?
|
| Nucleic Acid Conformation | 1 | 2008 | 156 | 0.270 |
Why?
|
| Fishes | 1 | 2007 | 59 | 0.270 |
Why?
|
| Arsenic | 1 | 2009 | 151 | 0.260 |
Why?
|
| RNA | 1 | 2008 | 266 | 0.250 |
Why?
|
| Base Pair Mismatch | 1 | 2006 | 15 | 0.250 |
Why?
|
| DNA, Viral | 1 | 2008 | 323 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 4 | 2014 | 301 | 0.240 |
Why?
|
| Soil | 1 | 2007 | 170 | 0.240 |
Why?
|
| Porosity | 2 | 2015 | 42 | 0.230 |
Why?
|
| Tungsten | 1 | 2025 | 8 | 0.230 |
Why?
|
| Sensitivity and Specificity | 3 | 2015 | 602 | 0.230 |
Why?
|
| Photochemical Processes | 1 | 2025 | 19 | 0.230 |
Why?
|
| Catalysis | 1 | 2025 | 191 | 0.220 |
Why?
|
| Immunotherapy | 1 | 2025 | 137 | 0.210 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 174 | 0.210 |
Why?
|
| Base Sequence | 3 | 2012 | 997 | 0.210 |
Why?
|
| Luminescence | 1 | 2023 | 23 | 0.200 |
Why?
|
| Indolizines | 1 | 2023 | 4 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 290 | 0.190 |
Why?
|
| Animals | 9 | 2015 | 16695 | 0.190 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 1058 | 0.190 |
Why?
|
| Drug Carriers | 2 | 2015 | 169 | 0.190 |
Why?
|
| HIV-1 | 1 | 2008 | 747 | 0.180 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 254 | 0.180 |
Why?
|
| Equipment Failure Analysis | 2 | 2011 | 45 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2014 | 273 | 0.170 |
Why?
|
| Equipment Design | 2 | 2011 | 143 | 0.170 |
Why?
|
| Male | 7 | 2017 | 22779 | 0.160 |
Why?
|
| Protein Binding | 2 | 2021 | 1076 | 0.160 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2009 | 71 | 0.150 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2012 | 184 | 0.150 |
Why?
|
| Immunologic Techniques | 1 | 2016 | 12 | 0.130 |
Why?
|
| Anisotropy | 1 | 2017 | 33 | 0.130 |
Why?
|
| Explosive Agents | 1 | 2016 | 5 | 0.130 |
Why?
|
| RNA Viruses | 1 | 2016 | 22 | 0.130 |
Why?
|
| Infrared Rays | 1 | 2016 | 17 | 0.130 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2016 | 4 | 0.130 |
Why?
|
| Cell Count | 1 | 2016 | 140 | 0.120 |
Why?
|
| Malaria Vaccines | 1 | 2015 | 21 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2015 | 17 | 0.120 |
Why?
|
| Rivers | 1 | 2015 | 50 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 62 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2015 | 37 | 0.110 |
Why?
|
| Coloring Agents | 1 | 2015 | 56 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2015 | 117 | 0.110 |
Why?
|
| Glutathione | 1 | 2015 | 170 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 277 | 0.110 |
Why?
|
| Methylene Blue | 1 | 2014 | 7 | 0.110 |
Why?
|
| Indocyanine Green | 1 | 2014 | 4 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 28 | 0.110 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 49 | 0.110 |
Why?
|
| Protozoan Proteins | 1 | 2015 | 196 | 0.100 |
Why?
|
| Antibodies | 1 | 2013 | 140 | 0.100 |
Why?
|
| Iodides | 1 | 2013 | 5 | 0.100 |
Why?
|
| Salts | 1 | 2013 | 18 | 0.100 |
Why?
|
| Rhodamines | 1 | 2012 | 23 | 0.100 |
Why?
|
| Enterotoxins | 1 | 2012 | 33 | 0.100 |
Why?
|
| Fluoroimmunoassay | 1 | 2012 | 2 | 0.100 |
Why?
|
| Antiviral Agents | 1 | 2014 | 189 | 0.090 |
Why?
|
| Rabbits | 1 | 2012 | 292 | 0.090 |
Why?
|
| Microbial Viability | 1 | 2012 | 42 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2012 | 30 | 0.090 |
Why?
|
| Female | 4 | 2025 | 24018 | 0.090 |
Why?
|
| Carbocyanines | 1 | 2011 | 14 | 0.090 |
Why?
|
| Antibodies, Immobilized | 1 | 2011 | 8 | 0.090 |
Why?
|
| Food Microbiology | 1 | 2011 | 38 | 0.090 |
Why?
|
| Gold Compounds | 1 | 2011 | 4 | 0.090 |
Why?
|
| Hazardous Substances | 1 | 2011 | 18 | 0.090 |
Why?
|
| Chlorides | 1 | 2011 | 59 | 0.090 |
Why?
|
| Porphyrins | 1 | 2011 | 57 | 0.090 |
Why?
|
| Imidazoles | 1 | 2011 | 138 | 0.080 |
Why?
|
| Bacterial Toxins | 1 | 2011 | 50 | 0.080 |
Why?
|
| Mutagens | 1 | 2011 | 76 | 0.080 |
Why?
|
| Absorption | 1 | 2010 | 22 | 0.080 |
Why?
|
| Photochemistry | 1 | 2010 | 58 | 0.080 |
Why?
|
| Quantum Theory | 1 | 2010 | 79 | 0.080 |
Why?
|
| Metals | 1 | 2011 | 113 | 0.080 |
Why?
|
| Cells, Cultured | 2 | 2014 | 1617 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1559 | 0.080 |
Why?
|
| Nonlinear Dynamics | 1 | 2009 | 35 | 0.080 |
Why?
|
| Picolinic Acids | 1 | 2009 | 12 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2011 | 287 | 0.070 |
Why?
|
| Receptor, erbB-2 | 1 | 2010 | 149 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2009 | 53 | 0.070 |
Why?
|
| Linear Models | 1 | 2009 | 311 | 0.070 |
Why?
|
| Models, Molecular | 2 | 2010 | 875 | 0.070 |
Why?
|
| Pyridines | 1 | 2009 | 134 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 59 | 0.070 |
Why?
|
| Cell Line | 1 | 2011 | 1416 | 0.070 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 2006 | 9 | 0.070 |
Why?
|
| Cell Survival | 3 | 2015 | 934 | 0.060 |
Why?
|
| Sodium Chloride | 1 | 2006 | 54 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2006 | 54 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 845 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2016 | 189 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 860 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1848 | 0.050 |
Why?
|
| Algorithms | 1 | 2006 | 508 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2014 | 448 | 0.050 |
Why?
|
| DNA Damage | 2 | 2014 | 358 | 0.040 |
Why?
|
| Biofilms | 1 | 2023 | 178 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2014 | 990 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2015 | 34 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 2015 | 78 | 0.030 |
Why?
|
| Neomycin | 1 | 2015 | 5 | 0.030 |
Why?
|
| Penicillins | 1 | 2015 | 11 | 0.030 |
Why?
|
| Tetracycline | 1 | 2015 | 17 | 0.030 |
Why?
|
| Antibodies, Protozoan | 1 | 2015 | 82 | 0.030 |
Why?
|
| Toxicity Tests | 1 | 2015 | 45 | 0.030 |
Why?
|
| Amines | 1 | 2015 | 40 | 0.030 |
Why?
|
| Organic Chemicals | 1 | 2015 | 35 | 0.030 |
Why?
|
| Tissue Transplantation | 1 | 2014 | 3 | 0.030 |
Why?
|
| Virus Internalization | 1 | 2014 | 36 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 122 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 686 | 0.030 |
Why?
|
| DNA Repair | 1 | 2014 | 196 | 0.020 |
Why?
|
| Singlet Oxygen | 1 | 2011 | 5 | 0.020 |
Why?
|
| Carboxylic Acids | 1 | 2011 | 15 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2014 | 400 | 0.020 |
Why?
|
| Dermatitis, Phototoxic | 1 | 2011 | 5 | 0.020 |
Why?
|
| Citrates | 1 | 2011 | 20 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1586 | 0.020 |
Why?
|
| Amides | 1 | 2011 | 72 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2011 | 118 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 385 | 0.020 |
Why?
|